Trial
NCT05605756
BOTOX Effects on Seizure Severity and Susceptibility
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Beth Israel Deaconess Medical Center
Collaborators
AbbVie
Condition
Drug-resistant Focal Seizure
Intervention
OnabotulinumtoxinA 145 UNT [Botox]
Why stopped
Failure to recruit subjects.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-29